ALB and early-onset autosomal dominant Alzheimer disease: Albumin is able to bind to the precursor agent of the AD, amyloid-beta (Aβ) in the blood (34, 37), preventing its deposition in the brain and potentially slowing the pathological progression of Alzheimer’s disease.